ID

34967

Beschreibung

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02061423

Link

https://clinicaltrials.gov/show/NCT02061423

Stichworte

Versionen (1)
  1. 06.02.19 06.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

6. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02061423

Englisch

Eligibility Breast Cancer NCT02061423

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
women ≥ 18 years.
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subjects with her-2 expressing stage i - iii breast cancer with residual disease in the breast or axillary nodes post-neoadjuvant chemotherapy.
Beschreibung

HER2-positive carcinoma of breast TNM Breast tumor staging | Residual Tumor Breast | Residual Tumor Axillary lymph nodes | Status post Chemotherapy Neoadjuvant

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0474926
UMLS CUI [2,1]
C0543478
UMLS CUI [2,2]
C0006141
UMLS CUI [3,1]
C0543478
UMLS CUI [3,2]
C0729594
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0600558
women of childbearing age with a negative pregnancy serum test documented prior to enrollment.
Beschreibung

Childbearing Potential Serum pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
subjects with ecog performance status score of 0 or 1.
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
women of childbearing potential must agree to use a medically acceptable form of birth control (medically accepted methods: birth control pills, condoms and spermicidal lubricants, intrauterine device, and diaphragm) during their participation in the study.
Beschreibung

Childbearing Potential Contraceptive methods | Contraceptives, Oral | Female Condoms | Lubricants Spermicidal | Intrauterine Devices | Vaginal contraceptive diaphragm

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0009905
UMLS CUI [3]
C0221829
UMLS CUI [4,1]
C0282222
UMLS CUI [4,2]
C0419533
UMLS CUI [5]
C0021900
UMLS CUI [6]
C0042241
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating females.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subjects with positive hiv or hepatitis c at baseline by self report.
Beschreibung

HIV Seropositivity | Hepatitis C positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1112419
subjects with coagulopathies, including thrombocytopenia with platelet count <75,000, inr > 1.5 and partial thromboplastin time > 50 sec.
Beschreibung

Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding

Datentyp

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0040034
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0525032
UMLS CUI [5]
C1531697
subjects with muga < 50% ef.
Beschreibung

Cardiac ejection fraction MUGA

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0521317
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
Beschreibung

Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0521987
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02061423

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
women ≥ 18 years.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
HER2-positive carcinoma of breast TNM Breast tumor staging | Residual Tumor Breast | Residual Tumor Axillary lymph nodes | Status post Chemotherapy Neoadjuvant
Item
subjects with her-2 expressing stage i - iii breast cancer with residual disease in the breast or axillary nodes post-neoadjuvant chemotherapy.
boolean
C1960398 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0543478 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C0543478 (UMLS CUI [3,1])
C0729594 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0600558 (UMLS CUI [4,3])
Childbearing Potential Serum pregnancy test negative
Item
women of childbearing age with a negative pregnancy serum test documented prior to enrollment.
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
ECOG performance status
Item
subjects with ecog performance status score of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Contraceptives, Oral | Female Condoms | Lubricants Spermicidal | Intrauterine Devices | Vaginal contraceptive diaphragm
Item
women of childbearing potential must agree to use a medically acceptable form of birth control (medically accepted methods: birth control pills, condoms and spermicidal lubricants, intrauterine device, and diaphragm) during their participation in the study.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C0221829 (UMLS CUI [3])
C0282222 (UMLS CUI [4,1])
C0419533 (UMLS CUI [4,2])
C0021900 (UMLS CUI [5])
C0042241 (UMLS CUI [6])
Informed Consent
Item
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity | Hepatitis C positive
Item
subjects with positive hiv or hepatitis c at baseline by self report.
boolean
C0019699 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding
Item
subjects with coagulopathies, including thrombocytopenia with platelet count <75,000, inr > 1.5 and partial thromboplastin time > 50 sec.
boolean
C0005779 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0525032 (UMLS CUI [4])
C1531697 (UMLS CUI [5])
Cardiac ejection fraction MUGA
Item
subjects with muga < 50% ef.
boolean
C0232174 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial
Item
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
boolean
C0521987 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video